170 related articles for article (PubMed ID: 17378544)
1. Structure-activity relationships of 2,N(6),5'-substituted adenosine derivatives with potent activity at the A2B adenosine receptor.
Adachi H; Palaniappan KK; Ivanov AA; Bergman N; Gao ZG; Jacobson KA
J Med Chem; 2007 Apr; 50(8):1810-27. PubMed ID: 17378544
[TBL] [Abstract][Full Text] [Related]
2. A2B adenosine receptor agonists: synthesis and biological evaluation of 2-phenylhydroxypropynyl adenosine and NECA derivatives.
Vittori S; Costanzi S; Lambertucci C; Portino FR; Taffi S; Volpini R; Klotz KN; Cristalli G
Nucleosides Nucleotides Nucleic Acids; 2004; 23(1-2):471-81. PubMed ID: 15043167
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships of truncated C2- or C8-substituted adenosine derivatives as dual acting A₂A and A₃ adenosine receptor ligands.
Hou X; Majik MS; Kim K; Pyee Y; Lee Y; Alexander V; Chung HJ; Lee HW; Chandra G; Lee JH; Park SG; Choi WJ; Kim HO; Phan K; Gao ZG; Jacobson KA; Choi S; Lee SK; Jeong LS
J Med Chem; 2012 Jan; 55(1):342-56. PubMed ID: 22142423
[TBL] [Abstract][Full Text] [Related]
4. A functional screening of adenosine analogues at the adenosine A2B receptor: a search for potent agonists.
de Zwart M; Link R; von Frijtag Drabbe Künzel JK; Cristalli G; Jacobson KA; Townsend-Nicholson A; IJzerman AP
Nucleosides Nucleotides; 1998 Jun; 17(6):969-85. PubMed ID: 9708319
[TBL] [Abstract][Full Text] [Related]
5. The hybrid molecule, VCP746, is a potent adenosine A2B receptor agonist that stimulates anti-fibrotic signalling.
Vecchio EA; Chuo CH; Baltos JA; Ford L; Scammells PJ; Wang BH; Christopoulos A; White PJ; May LT
Biochem Pharmacol; 2016 Oct; 117():46-56. PubMed ID: 27520486
[TBL] [Abstract][Full Text] [Related]
6. (N)-methanocarba 2,N6-disubstituted adenine nucleosides as highly potent and selective A3 adenosine receptor agonists.
Tchilibon S; Joshi BV; Kim SK; Duong HT; Gao ZG; Jacobson KA
J Med Chem; 2005 Mar; 48(6):1745-58. PubMed ID: 15771421
[TBL] [Abstract][Full Text] [Related]
7. Capadenoson, a clinically trialed partial adenosine A
Baltos JA; Vecchio EA; Harris MA; Qin CX; Ritchie RH; Christopoulos A; White PJ; May LT
Biochem Pharmacol; 2017 Jul; 135():79-89. PubMed ID: 28344125
[TBL] [Abstract][Full Text] [Related]
8. 2-Substituted adenosine derivatives: affinity and efficacy at four subtypes of human adenosine receptors.
Gao ZG; Mamedova LK; Chen P; Jacobson KA
Biochem Pharmacol; 2004 Nov; 68(10):1985-93. PubMed ID: 15476669
[TBL] [Abstract][Full Text] [Related]
9. 5'-O-alkyl ethers of N,2-substituted adenosine derivatives: partial agonists for the adenosine A1 and A3 receptors.
van Tilburg EW; van der Klein PA; von Frijtag Drabbe Künzel J; de Groote M; Stannek C; Lorenzen A; IJzerman AP
J Med Chem; 2001 Aug; 44(18):2966-75. PubMed ID: 11520205
[TBL] [Abstract][Full Text] [Related]
10. N6-methoxy-2-alkynyladenosine derivatives as highly potent and selective ligands at the human A3 adenosine receptor.
Volpini R; Dal Ben D; Lambertucci C; Taffi S; Vittori S; Klotz KN; Cristalli G
J Med Chem; 2007 Mar; 50(6):1222-30. PubMed ID: 17309246
[TBL] [Abstract][Full Text] [Related]
11. 2,8-Disubstituted adenosine derivatives as partial agonists for the adenosine A2A receptor.
van Tilburg EW; Gremmen M; von Frijtag Drabbe Künzel J; de Groote M; IJzerman AP
Bioorg Med Chem; 2003 May; 11(10):2183-92. PubMed ID: 12713828
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of novel 1-deoxy-1-[6-[((hetero)arylcarbonyl)hydrazino]- 9H-purin-9-yl]-N-ethyl-beta-D-ribofuranuronamide derivatives as useful templates for the development of A2B adenosine receptor agonists.
Baraldi PG; Preti D; Tabrizi MA; Fruttarolo F; Romagnoli R; Carrion MD; Cara LC; Moorman AR; Varani K; Borea PA
J Med Chem; 2007 Jan; 50(2):374-80. PubMed ID: 17228880
[TBL] [Abstract][Full Text] [Related]
13. N(6)-alkyl-2-alkynyl derivatives of adenosine as potent and selective agonists at the human adenosine A(3) receptor and a starting point for searching A(2B) ligands.
Volpini R; Costanzi S; Lambertucci C; Taffi S; Vittori S; Klotz KN; Cristalli G
J Med Chem; 2002 Jul; 45(15):3271-9. PubMed ID: 12109910
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships of truncated adenosine derivatives as highly potent and selective human A3 adenosine receptor antagonists.
Pal S; Choi WJ; Choe SA; Heller CL; Gao ZG; Chinn M; Jacobson KA; Hou X; Lee SK; Kim HO; Jeong LS
Bioorg Med Chem; 2009 May; 17(10):3733-8. PubMed ID: 19375920
[TBL] [Abstract][Full Text] [Related]
15. Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells.
Klotz KN; Hessling J; Hegler J; Owman C; Kull B; Fredholm BB; Lohse MJ
Naunyn Schmiedebergs Arch Pharmacol; 1998 Jan; 357(1):1-9. PubMed ID: 9459566
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of molecular modeling of agonist binding in light of the crystallographic structure of an agonist-bound A₂A adenosine receptor.
Deflorian F; Kumar TS; Phan K; Gao ZG; Xu F; Wu H; Katritch V; Stevens RC; Jacobson KA
J Med Chem; 2012 Jan; 55(1):538-52. PubMed ID: 22104008
[TBL] [Abstract][Full Text] [Related]
17. 2-Phenylhydroxypropynyladenosine derivatives as high potent agonists at A2B adenosine receptor subtype.
Lambertucci C; Volpini R; Costanzi S; Taffi S; Vittori S; Cristalli G
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):809-12. PubMed ID: 14565284
[TBL] [Abstract][Full Text] [Related]
18. N6-Substituted adenosine derivatives: selectivity, efficacy, and species differences at A3 adenosine receptors.
Gao ZG; Blaustein JB; Gross AS; Melman N; Jacobson KA
Biochem Pharmacol; 2003 May; 65(10):1675-84. PubMed ID: 12754103
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and biological activity of N6-substituted-4'-thioadenosines at the human A3 adenosine receptor.
Jeong LS; Lee HW; Kim HO; Jung JY; Gao ZG; Duong HT; Rao S; Jacobson KA; Shin DH; Lee JA; Gunaga P; Lee SK; Jin DZ; Chun MW; Moon HR
Bioorg Med Chem; 2006 Jul; 14(14):4718-30. PubMed ID: 16603368
[TBL] [Abstract][Full Text] [Related]
20. Ligand-Independent Adenosine A2B Receptor Constitutive Activity as a Promoter of Prostate Cancer Cell Proliferation.
Vecchio EA; Tan CY; Gregory KJ; Christopoulos A; White PJ; May LT
J Pharmacol Exp Ther; 2016 Apr; 357(1):36-44. PubMed ID: 26791603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
